Mouse Study Reveals Potential Combination Therapy for Ovarian Cancer

Mouse Study Reveals Potential Combination Therapy for Ovarian Cancer
Researchers at the Johns Hopkins Kimmel Cancer Center have discovered a combination therapy that may hold promise in halting ovarian cancer progression. The combination of epigenetic therapy and immunotherapy reduced tumor burden and extended survival in a mouse model of epithelial ovarian cancer (EOC). The study, “Epigenetic therapy activates type I interferon signaling in murine

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *